Get a free sample of Photopheresis Products Market
Thank you!
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Photopheresis Products Market
Thank you!
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Photopheresis Products Market Size
Photopheresis Products Market size was valued at over USD 270 million in 2022 and is projected to reach more than USD 440 million by 2032 due to growing incidence of cutaneous T-cell lymphoma.
Photopheresis products are used in a medical procedure known as extracorporeal photopheresis (ECP). This procedure involves the collection of a patient's blood, separation of specific components, treatment of those components with a photosensitizing agent, exposure of the treated components to ultraviolet (UV) light, and reinfusion of the treated blood components back into the patient. Photopheresis is primarily used for the treatment of certain blood disorders and immune-mediated conditions which are determined through performing various blood tests and other related tests.. For instance, multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system. It is estimated that there are approximately 2.8 million people suffering from with MS globally.
Moreover, increasing incidence of cutaneous T-cell lymphoma (CTCL) which is a rare form of non-Hodgkin lymphoma that predominantly impacts the skin. It is characterized by the abnormal proliferation of T lymphocytes in the skin. For instance, according to the Surveillance, Epidemiology, and End Results (SEER) data, the age-adjusted incidence rate of CTCL in the U.S. is estimated to be around 6.4 cases per million individuals per year.
What is the share of closed system segment in photopheresis products industry?
The closed system segment held a notable revenue share of over USD 150 million in 2022 and will reach more than USD 240 million by 2032, as these closed systems are designed to minimize the risk of contamination during the photopheresis procedure.
How big is photopheresis products market?
The global market for photopheresis products was valued at over USD 270 million in 2022 and is projected to reach more than USD 440 million by 2032. The growing prevalence of autoimmune diseases is accelerating market growth as these products are primarily used for the treatment of certain blood disorders and immune-mediated conditions.
Why is the U.S. emerging as lucrative growth avenue for photopheresis products market players?
The U.S. region accounted for more than USD 95 million in 2022 and will be worth over USD 150 million by 2032, backed by the affordability of photopheresis products among the target population base and ongoing technological developments.
Who are the main contenders in photopheresis products industry space?
Haemonetics Corporation, Fresenius Kabi, Terumo Corporation, Macopharma, Mallinckrodt Pharmaceuticals, Med Tech Solutions GmbH, Thermo Fisher Scientific, Spectranetics, Therakos, among others.